VTX3232 - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

MINISO stock jumps 5.8% as YOYO crosses RMB1bn and U.S. retail growth accelerates

Why IKEA, eBay and fashion brands are turning secondhand shopping into a growth strategy

Tata Power targets 2.8 GW data-centre opportunity pipeline as Rs 15,000cr Mumbai grid plan advances

Fluence wins Vattenfall’s 1 GWh German battery storage contract as shares face pressure

Read More

Pharma Industry News

Ventyx Biosciences announces positive Phase 2 trial data for VTX3232 in obesity and cardiometabolic risk

Find out how Ventyx Biosciences’ VTX3232 is reshaping the obesity and cardiometabolic space through inflammation-targeted innovation.

bySoujanya Ravi

October 23, 2025

web analytics